| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Chuong Duong Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫17,500.00 |
| 52 Week High | ₫20,600.00 |
| 52 Week Low | ₫17,250.00 |
| Beta | 0 |
| 11 Month Change | -4.63% |
| 3 Month Change | -11.62% |
| 1 Year Change | -11.84% |
| 33 Year Change | 19.05% |
| 5 Year Change | 63.33% |
| Change since IPO | -39.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| CDC | VN Construction | VN Market | |
|---|---|---|---|
| 7D | -1.4% | 1.2% | 1.5% |
| 1Y | -11.8% | 3.7% | 10.9% |
Return vs Industry: CDC underperformed the VN Construction industry which returned 3.7% over the past year.
Return vs Market: CDC underperformed the VN Market which returned 10.9% over the past year.
Price Volatility
| CDC volatility | |
|---|---|
| CDC Average Weekly Movement | 1.2% |
| Construction Industry Average Movement | 5.3% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in VN Market | 7.6% |
| 10% least volatile stocks in VN Market | 2.6% |
Stable Share Price: CDC has not had significant price volatility in the past 3 months.
Volatility Over Time: CDC's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Hoang Van | www.acic.com.vn |
Chuong Duong Corp. engages in the construction and real estate business in Vietnam. It is involved in the construction and installation of bridges, soil improvement and infrastructure construction of international ports and phoenix islands, railway overpass-national roads, garden complex, apartment building, houses, residential and urban area, colleges, indoor sports stadium and football field, hotels, petroleum terminal, factories, power plants, and cargo warehouses; and real estate development. The company was formerly known as Eiffel Asia.
Chuong Duong Corp. Fundamentals Summary
| CDC fundamental statistics | |
|---|---|
| Market cap | ₫384.80b |
| Earnings (TTM) | ₫10.98b |
| Revenue (TTM) | ₫367.78b |
0.0x
P/E Ratio0.0x
P/S RatioIs CDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CDC income statement (TTM) | |
|---|---|
| Revenue | ₫367.78b |
| Cost of Revenue | ₫307.97b |
| Gross Profit | ₫59.81b |
| Other Expenses | ₫48.83b |
| Earnings | ₫10.98b |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CDC perform over the long term?
See historical performance and comparison